GTL001, a bivalent therapeutic vaccine against human papillomavirus 16 and 18, induces antigen-specific CD8(+) T cell responses leading to tumor regression

por Esquerré, Michaël, Bouillette-Marussig, Myriam, Goubier, Anne, Momot, Marie, Gonindard, Christophe, Keller, Hélène, Navarro, Astrid, Bissery, Marie-Christine
Publicado 2017